Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7553835 | MYLAN | Topical antifungal composition |
Oct, 2018
(5 years ago) | |
US8026238 | MYLAN | Topical antifungal composition |
Oct, 2018
(5 years ago) |
Market Authorisation Date: 12 June, 2007
Treatment: Treatment of seborrhea dermatitis in humans; Topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older
Dosage: AEROSOL, FOAM;TOPICAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5456851 | KRAMER | Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole |
Apr, 2014
(10 years ago) |
Market Authorisation Date: 10 October, 1997
Treatment: NA
Dosage: SHAMPOO;TOPICAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8735393 | ALMIRALL | Anhydrous topical skin preparations |
Dec, 2018
(5 years ago) | |
US7179475 | ALMIRALL | Anhydrous topical skin preparations |
Dec, 2018
(5 years ago) | |
US8232276 | ALMIRALL | Anhydrous topical skin preparations |
Nov, 2020
(3 years ago) |
Market Authorisation Date: 28 July, 2006
Treatment: Treatment of seborrhea dermatitis in humans
Dosage: GEL;TOPICAL